Increasing life expectancy in industrialized societies has resulted in a huge population of older adults with cardiovascular disease. Pharmacological treatment is the mainstay of therapy for these patients. In this extensive Review, Jerome Fleg and colleagues address the challenges associated with cardiovascular drug therapy in the elderly, as well as providing an in-depth discussion of specific disease states and drug types in this patient population.
- Jerome L. Fleg
- Wilbert S. Aronow
- William H. Frishman
